Takashi Matsumoto
Director/Miembro de la Junta en DAIICHI SANKYO CO., LTD. .
Origen de la red de primer grado Takashi Matsumoto.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 61 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Takashi Matsumoto a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| University of Tokyo | College/University | Graduate Degree Undergraduate Degree Graduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Keio University | College/University | Undergraduate Degree Corporate Officer/Principal Corporate Officer/Principal | |
Kitasato Daiichi Sankyo Vaccine Co., Ltd.
 Kitasato Daiichi Sankyo Vaccine Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Daiichi Sankyo Co., Ltd., Kitasato Daiichi Sankyo Vaccine Co., Ltd. develops, manufactures and distributes vaccines. The company is based in Kitamoto, Japan. Kitasato Daiichi Sankyo Vaccine Co. was acquired by Daiichi Sankyo Co., Ltd. from The Kitasato Institute on November 30, 2017. | Pharmaceuticals: Major | President President | |
| ADC THERAPEUTICS SA | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Compliance Officer | |
| JAPAN POST HOLDINGS CO., LTD. | Life/Health Insurance | President Director/Board Member | |
| Daiichi Sankyo Biotech Co. Ltd. | Chairman | ||
| Rutgers State University of New Jersey | College/University | Undergraduate Degree | |
| QUEST DIAGNOSTICS INCORPORATED | Services to the Health Industry | Corporate Officer/Principal | |
| REATA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| SOLID BIOSCIENCES INC. | Biotechnology | Director/Board Member | |
| SUMITOMO MITSUI FINANCIAL GROUP, INC. | Major Banks | President | |
Neurogene, Inc.
 Neurogene, Inc. BiotechnologyHealth Technology Neurogene, Inc. focuses on developing disease modifying therapeutics for severe neurologic diseases. Its pipeline includes multiple gene therapy products for ultra-rare diseases, as well as a novel technology that has the potential for use in monogenic autism spectrum disorders and indications not well suited for gene therapy. The company was founded by Rachel McMinn in January 2018 and is headquartered in New York, NY. | Biotechnology | Director/Board Member | |
The Robert Wood Johnson Foundation
 The Robert Wood Johnson Foundation Investment Trusts/Mutual FundsMiscellaneous The Robert Wood Johnson Foundation (RWJF) is an independent philanthropic organization headquartered in Princeton, New Jersey. The firm was founded in 1972 and is dedicated solely to health. RWJF funds a wide array of programs which are working to help build a national Culture of Health. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
| TAYSHA GENE THERAPIES, INC. | Biotechnology | President | |
SalioGen Therapeutics, Inc.
 SalioGen Therapeutics, Inc. BiotechnologyHealth Technology SalioGen Therapeutics, Inc. is a genetic medicine company based in Cambridge, MA. The company is advancing the Exact DNA Integration Technology (EDIT) platform, which is a mammal-derived genome engineering technology for use in potentially curative non-viral gene therapy. SalioGen Therapeutics has launched Gene Coding, a genetic medicine technology, to develop durable, broadly applicable genetic medicines using its EDIT platform. The company's mission is to transform the treatment paradigm for patients with inherited disorders. Jason F. Cole has been the CEO of the company since 2023. | Biotechnology | Director/Board Member | |
Jaguar Gene Therapy LLC
 Jaguar Gene Therapy LLC Medical/Nursing ServicesHealth Services Jaguar Gene Therapy LLC is a clinical stage biotechnology company based in Lake Forest, IL. Jaguar Gene Therapy LLC is dedicated to accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases. The company has a proven team of experts who have experience in bringing novel gene therapy treatments to patients and their families. Jaguar is rapidly advancing an initial pipeline of three programs, including targeting severe neurodevelopmental disorders, type 1 galactosemia, and type 1 diabetes. The company partner with Advanced Medicine Partners for manufacturing their therapeutics. Key investors include Deerfield Management Company, Arch Venture Partners, and Eli Lilly and Company. The company was founded by Daniel Gallo, and Joseph Nolan has been the CEO since 2020. | Medical/Nursing Services | Chief Tech/Sci/R&D Officer | |
Medocity, Inc.
 Medocity, Inc. Medical/Nursing ServicesHealth Services Medocity, Inc. develops a care platform that bridges the gap between the clinic and the patient?s home. It offers a patient-centric mobile solution that combines key aspects of disease-specific care into a platform that can be used on application and Web-based devices. The firm platform also tracks key symptoms and side effects in real time; displays reports and graphic summaries to understand the patient?s health status on a daily basis. The company is headquartered in Parsippany, NJ. | Medical/Nursing Services | Director/Board Member | |
International Federation of Pharmaceutical Manufacturers
 International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | Biotechnology | Corporate Officer/Principal | |
| University of Hitotsubashi | College/University | Undergraduate Degree | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| FUJIMORI KOGYO CO., LTD. | Industrial Specialties | Director/Board Member | |
| SONY GROUP CORPORATION | Computer Processing Hardware | Director/Board Member | |
| Tokyo Medical & Dental University | College/University | Doctorate Degree | |
| AJINOMOTO CO., INC. | Food: Specialty/Candy | Director/Board Member | |
| Osaka University | College/University | Graduate Degree | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Masters Business Admin | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Sanofi-Aventis Ltd.
 Sanofi-Aventis Ltd. Pharmaceuticals: MajorHealth Technology Sanofi-Aventis Ltd. provides pharmaceutical services. It focuses on cardiovascular medicine, thrombosis, oncology, metabolic disorders and diseases of the central nervous system. The company was founded in December 2004 and is headquartered in Guildford, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Nippon Wellcome Kk
 Nippon Wellcome Kk Pharmaceuticals: OtherHealth Technology Part of GSK Plc, Nippon Wellcome Kk is a Japanese company that researches, develops, manufactures, and markets pharmaceuticals. The company is located in Japan. Nippon Wellcome Kk was acquired by Glaxo Wellcome Plc on April 01, 1999. | Pharmaceuticals: Other | Corporate Officer/Principal | |
| JAPAN EXCHANGE GROUP, INC. | Investment Banks/Brokers | Director/Board Member | |
Sumitomo Life Insurance Co.
 Sumitomo Life Insurance Co. Life/Health InsuranceFinance Sumitomo Life Insurance Co. engages in the provision of life insurance services. It also sells investment trust and manages defined contribution pension plans. The company was founded in May 1907 and is headquartered in Osaka, Japan. | Life/Health Insurance | Director/Board Member | |
| The Society of Japanese Aerospace Companies | Chairman | ||
| Japan Vocational Ability Development Association | Chairman | ||
| Rutgers Robert Wood Johnson Medical School | College/University | Doctorate Degree | |
Spotlight Therapeutics, Inc.
 Spotlight Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Spotlight Therapeutics, Inc. engages in gene editing therapeutics. It focused in reprogramming tumor microenvironment. The company was founded by Alex Marson, Patrick Hsu, and Jacob Corn in 2017 and is headquartered in Hayward, CA. | Pharmaceuticals: Generic | Director/Board Member | |
| CENTESSA PHARMACEUTICALS PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| CELCUITY INC. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
| Albert Einstein College of Medicine, Inc. | College/University | Doctorate Degree | |
| Stony Brook University | College/University | Undergraduate Degree | |
| University of Connecticut | College/University | Corporate Officer/Principal | |
| PYXIS ONCOLOGY, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Daiichi Sankyo Pharmaceutical (Beijing) Co. Ltd.
 Daiichi Sankyo Pharmaceutical (Beijing) Co. Ltd. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo Pharmaceutical (Beijing) Co. Ltd. is based in Beijing, China. Part of Fosun International Holdings Ltd., Daiichi Sankyo Pharmaceutical (Beijing) Co. Ltd. is a Chinese company that manufactures and markets pharmaceuticals. The company was founded in 1998. Daiichi Sankyo Pharmaceutical (Beijing) Co. was acquired by Chongqing Yao Pharmaceutical Co., Ltd. from Daiichi Sankyo Co., Ltd. on August 31, 2022. | Pharmaceuticals: Major | Director/Board Member | |
| IOVANCE BIOTHERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
| MEI PHARMA, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
St. Luke's SRL Advanced Clinical Research Center, Inc.
 St. Luke's SRL Advanced Clinical Research Center, Inc. Miscellaneous Commercial ServicesCommercial Services St. Luke's SRL Advanced Clinical Research Center, Inc. engages in specimen inspection, research support for clinical examinations, surveys, research and examinations related to treatment and prevention of disease and information provision activities. The company was founded on April 3, 2017 and is headquartered in Tokyo, Japan. | Miscellaneous Commercial Services | Director/Board Member |
Estadísticas
Internacional
| Estados Unidos | 25 |
| Japón | 20 |
| Reino Unido | 4 |
| Suiza | 3 |
| India | 2 |
Sectorial
| Health Technology | 24 |
| Consumer Services | 12 |
| Finance | 6 |
| Health Services | 4 |
| Miscellaneous | 2 |
Operativa
| Director/Board Member | 108 |
| Corporate Officer/Principal | 61 |
| Independent Dir/Board Member | 32 |
| Chairman | 26 |
| President | 17 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Kazuaki Kama | 15 |
| Sukumar Nagendran | 15 |
| Sawako Nohara | 13 |
| Takashi Okimoto | 10 |
| Hiroshi Hirabayashi | 10 |
| Kunio Ishihara | 10 |
| Antoine Yver | 9 |
| Jay Feingold | 7 |
| Tsuguya Fukui | 7 |
| Susan Romanus | 6 |
| Yoshifumi Nishikawa | 6 |
| Francis Plat | 6 |
| Hiroshi Toda | 6 |
| Noritaka Uji | 6 |
| Takashi Shoda | 6 |
- Bolsa de valores
- Insiders
- Takashi Matsumoto
- Conexiones Empresas
